Skip to main content

Table 3 Hazard ratios for outcomes estimated by weighted Cox proportional hazard model

From: Association between alpha blocker use and the risk of fractures in patients with chronic kidney disease: a cohort study

A. Males

Outcome name

 

Hazard ratio (95% CI)

First hospitalization due to all fractures

AB for HT

reference

non-AB

0.70 (0.38–1.28); p = 0.242

AB for VD

1.33 (0.67–2.66); p = 0.418

First hospitalization due to femur fractures

AB for HT

reference

non-AB

0.65 (0.31–1.34); p = 0.242

AB for VD

1.43 (0.62–3.29); p = 0.398

First hospitalization due to vertebral fractures

AB for HT

reference

non-AB

0.80 (0.27–2.43); p = 0.700

AB for VD

1.13 (0.33–3.88): p = 0.842

B. Females

Outcome name

 

Hazard ratio (95% CI)

First hospitalization due to all fractures

AB for HT

reference

non-AB

1.06 (0.56–1.99); p = 0.854

AB for VD

2.28 (1.01–5.16); p = 0.048

First hospitalization due to femur fractures

AB for HT

reference

non-AB

1.14 (0.52–2.51); p = 0.746

AB for VD

1.59 (0.57–4.42); p = 0.376

First hospitalization due to vertebral fractures

AB for HT

reference

non-AB

0.94 (0.32–2.74); p = 0.911

AB for VD

3.50 (0.93–13.17); p = 0.063

  1. Abbreviations AB Alpha blocker, CI Confidence interval, HT Hypertension, VD Voiding dysfunction